1. Taiwan Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
PharmaEngine, Inc.

PharmaEngine, Inc.

TTPEX:4162
56.20
TWD
0.00
(0.00%)
3.74EPS
16.28P/E
8.76BMarket Cap
Nov 11Next Earn

Latest Stock Split

Jul 26, 2017

6:5

For every 5 shares held, investors received 6. The price per share adjusted from $221.00 to $184.17.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data
Stock Splits APIChatGPT

Stock Split History

  1. Jul 26, 2017
    Before$221.00
    Split ratio6:5
    After$184.17
    Forward
  2. Jul 25, 2016
    Before$233.00
    Split ratio6:5
    After$194.17
    Forward
  3. Aug 28, 2013
    Before$207.50
    Split ratio415:407
    After$203.50
    Forward

About PharmaEngine, Inc. stock splits

PharmaEngine, Inc. (TPEX:4162) operates in the Pharmaceuticals: major industry.

PharmaEngine, Inc. company overview

When did PharmaEngine, Inc. stock split?

PharmaEngine, Inc.'s most recent stock split was on July 26, 2017. It was a 6-for-5 forward split, so shareholders received 6 shares for every 5 they held.

What is PharmaEngine, Inc.'s stock split history?

PharmaEngine, Inc. (TPEX:4162) has split its stock 3 times: a 415-for-407 split on August 28, 2013, a 6-for-5 split on July 25, 2016, and a 6-for-5 split on July 26, 2017.

How many times has PharmaEngine, Inc. stock split?

PharmaEngine, Inc. has split its stock 3 times. This history records 3 forward splits between August 28, 2013 and July 26, 2017.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In PharmaEngine, Inc.'s 6-for-5 split on July 26, 2017, every 5 shares became 6 shares.

Will PharmaEngine, Inc. split its stock again?

PharmaEngine, Inc. has not announced a new split in our records. Its most recent split was on July 26, 2017, 9 years ago. Companies announce splits in advance, and any new TPEX:4162 split will appear on this page.